Landscapes / Targets
CALR (mutant)
2 drugs act on CALR (mutant), in 5 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 15 Jun 2029Phase 3 trial completes | |||
| Next date | 15 Jun 2029 · Phase 3 trial completes | ||||
| Also tested for | Myeloproliferative Neoplasms, Essential Thrombocythemia | ||||
| Open drug page | |||||
— |
Johnson & Johnson (Janssen) · Public JNJ |
Phase 1 | 14 Jun 2027Phase 1 trial completes | ||
| Next date | 14 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Neoplasms | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026